Study to Assess Eradication of Nasal Carriage of Staphylococcus Aureus (SA) With Mupirocin (Bactroban 2% Nasal Ointment)

NCT02284555 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Staphylococcal Infection

Interventions

DRUG: Mupirocin

Sponsor

Destiny Pharma Plc